OXGENE describes how self-silencing adenoviral vectors can deliver high-quality, high-titer AAV and even grow AAV from AAV Until very recently, adeno-associated virus (AAV) had an excellent safety ...
Although the targets of biomanufacturing have evolved from therapeutic proteins to “advanced therapies” and now to gene therapies, the issues and solutions remain the same. The production of safe, ...
Simple Plex AAV assays combine industry leading AAV antibody reagents from PROGEN with convenience and simplicity of the fully automated Ella platform. MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback